TXN

Texas Instruments Incorporated

NASDAQ • USD • TECHNOLOGY • SEMICONDUCTORS

Current Price $280.89 1 Year: +70.74%

52-Week Range

$152.73 $287.83

Current price is 94.9% of 52-week range

Key Metrics

Market Cap $241.3B
P/E Ratio N/A
Current Ratio N/A
EPS
Dividend Yield N/A
ATR(14) $9.24
Beta 1.0
PEG Ratio N/A
ROE N/A
Operating Earnings Growth Rate 2.29%

AI Overview

Last updated about 1 month ago

Texas Instruments is a high-quality analog and embedded processing supplier with deep customer relationships, long product lifecycles, and strong scale advantages in manufacturing and distribution, which tend to translate into durable pricing power over cycles. Recent product announcements tied to higher-voltage data center power architectures and edge AI MCUs reinforce TI’s positioning in power management and industrial/auto end markets, though near-term demand remains cyclical. The core moat still rests on breadth of catalog, reliability, and internal capacity that smaller peers struggle to match.

Profitability remains strong even in a softer tape: Q4 2025 revenue was $4.42B with EPS of $1.27, and management guided Q1 2026 revenue of $4.32–$4.68B with EPS of $1.22–$1.48. Cash generation is healthy (2025 operating cash flow cited at $7.2B and free cash flow about $2.9B), but elevated capex (2025 cited at $4.6B) can pressure free cash flow in downcycles. At about $195/share, TXN trades around 33x trailing EPS (~$5.48), a premium that requires confidence in a multi-year recovery; the dividend is $1.42 quarterly ($5.68 annual).

Over the next 12 months, the bull case hinges on a clearer analog/industrial inventory normalization driving sequential revenue improvement and better factory loading, plus incremental AI-power and automotive content wins. Key risks are a slower-than-expected industrial recovery, margin pressure from underutilization while TI continues heavy U.S. manufacturing investment, and valuation compression if rates rise or earnings revisions turn down. For DIY investors, TXN fits best as a quality compounder to average into on weakness rather than chase at peak multiples.

Recommendation: HOLD. The business quality and shareholder returns are compelling, but the current valuation leaves limited room for error while the cycle and utilization recovery are still unfolding.

Price & Profitability History

1 Year change: +70.74% (+$116.38)

Log in